Country: কানাডা
ভাষা: ইংরেজি
সূত্র: Health Canada
DICLOFENAC SODIUM
PHARMASCIENCE INC
M01AB05
DICLOFENAC
50MG
TABLET (ENTERIC-COATED)
DICLOFENAC SODIUM 50MG
ORAL
100/500
Prescription
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Active ingredient group (AIG) number: 0114417002; AHFS:
CANCELLED POST MARKET
2022-02-14
PRODUCT MONOGRAPH PR PMS-DICLOFENAC PR PMS-DICLOFENAC-SR (diclofenac sodium) 50 mg Enteric-Coated Tablets 75 and 100 mg Slow-Release Tablets 50 and 100 mg Suppositories Acetic Acid Derivatives and Related Substances PHARMASCIENCE INC. DATE OF REVISION: 6111 Royalmount Ave., Suite 100, March 26, 2020 Montréal, Québec H4P 2T4 www.pharmascience.com CONTROL NO.: 237237 _pms-DICLOFENAC & pms-DICLOFENAC-SR Product Monograph_ _Page 2 of 40 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................... 3 INDICATIONS AND CLINICAL USE ..................................................................................... 3 CONTRAINDICATIONS .......................................................................................................... 4 WARNINGS AND PRECAUTIONS ......................................................................................... 5 ADVERSE REACTIONS ......................................................................................................... 16 DRUG INTERACTIONS ......................................................................................................... 18 DOSAGE AND ADMINISTRATION ..................................................................................... 21 OVERDOSAGE ....................................................................................................................... 23 ACTION AND CLINICAL PHARMACOLOGY ................................................................... 23 STORAGE AND STABILITY ................................................................................................. 25 DOSAGE FORMS, COMPOSITION AND PACKAGING .................................................... 26 PART II: SCIENTIFIC INFORMATION ............................................................................... 27 PHARMACEUTICAL INFORMATION .................................................. সম্পূর্ণ নথি পড়ুন